We have data on 99 companies that use SnpEff. The companies using SnpEff are most often found in United States and in the Higher Education industry. SnpEff is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for SnpEff usage goes back as far as 5 years and 6 months.
Company | University of Arizona |
Website | arizona.edu |
Country | United States |
Revenue | >1000M |
Company Size | >10000 |
Company | International Business Machines Corporation |
Website | ibm.com |
Country | United States |
Revenue | >1000M |
Company Size | >10000 |
Company | Booz Allen Hamilton Holding Corporation |
Website | boozallen.com |
Country | United States |
Revenue | >1000M |
Company Size | >10000 |
Company | NYGC |
Website | nygenome.org |
Country | United States |
Revenue | 10M-50M |
Company Size | 200-500 |
Company | Regeneron Pharmaceuticals Inc |
Website | regeneron.com |
Country | United States |
Revenue | >1000M |
Company Size | >10000 |
Company | Website | Country | Revenue | Company Size |
---|---|---|---|---|
University of Arizona | arizona.edu | United States | >1000M | >10000 |
International Business Machines Corporation | ibm.com | United States | >1000M | >10000 |
Booz Allen Hamilton Holding Corporation | boozallen.com | United States | >1000M | >10000 |
NYGC | nygenome.org | United States | 10M-50M | 200-500 |
Regeneron Pharmaceuticals Inc | regeneron.com | United States | >1000M | >10000 |
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Healthcare. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Healthcare category, SnpEff has a market share of about 0.1%. Other major and competing products in this category include:
SnpEff is an open source tool that annotates variants and predicts their effects on genes by using an interval forest approach. This program takes pre-determined variants listed in a data file that contains the nucleotide change and its position and predicts if the variants are deleterious.
Looking at SnpEff customers by industry, we find that Higher Education (27%), Biotechnology (22%), Hospital & Health Care (13%) and Research (8%) are the largest segments.
61% of SnpEff customers are in United States, 9% are in India and 5% are in Canada.
Of all the customers that are using SnpEff, a majority (55%) are large (>1000 employees), 14% are small (<50 employees) and 21% are medium-sized.
Of all the customers that are using SnpEff, a majority (52%) are large (>$1000M), 26% are small (<$50M) and 10% are medium-sized.